nach oben

Reactions Weekly

Erschienen in:

01.09.2021 | Case report

AZD-1222

Vaccine-induced immune cerebral venous thrombosis and thrombocytopaenia syndrome: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Geeraerts T, et al. Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience. Anaesthesia, Critical Care and Pain Medicine 40: No. 4, Aug 2021. Available from: URL: http://doi.org/10.1016/j.accpm.2021.100889

Titel: AZD-1222
Vaccine-induced immune cerebral venous thrombosis and thrombocytopaenia syndrome: 2 case reports
Publikationsdatum: 01.09.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-02008-3

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

AZD-1222

Vaccine-induced immune cerebral venous thrombosis and thrombocytopaenia syndrome: 2 case reports

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Ergometrine/misoprostol/oxytocin

Multiple drugs

Cisatracurium besilate/dexamethasone/remdesivir

Pembrolizumab

Aflibercept

Bendamustine